{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20211207",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "69516",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761172s002lbl.pdf",
              "date": "20211208",
              "type": "Label"
            },
            {
              "id": "69794",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/761172Orig1s002ltr.pdf",
              "date": "20211228",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "11",
          "submission_status": "AP",
          "submission_status_date": "20260218",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "85074",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/761172Orig1s011ltr.pdf",
              "date": "20260219",
              "type": "Letter"
            },
            {
              "id": "85142",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761172s011lbl.pdf",
              "date": "20260224",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20201221",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "65650",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761172s000lbl.pdf",
              "date": "20201221",
              "type": "Label"
            },
            {
              "id": "65695",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/761172Orig1s000ltr.pdf",
              "date": "20201223",
              "type": "Letter"
            },
            {
              "id": "65897",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/761172Orig1s000TOC.html",
              "date": "20210112",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20241226",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "80760",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761172s008lbl.pdf",
              "date": "20241227",
              "type": "Label"
            },
            {
              "id": "80769",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761172Orig1s008ltr.pdf",
              "date": "20241227",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20220519",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "71110",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761172Orig1s004ltr.pdf",
              "date": "20220520",
              "type": "Letter"
            },
            {
              "id": "71120",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761172Orig1s004lbl.pdf",
              "date": "20220520",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "BLA761172",
      "sponsor_name": "RIDGEBACK BIOTHERAPEUTICS",
      "openfda": {
        "application_number": [
          "BLA761172"
        ],
        "brand_name": [
          "EBANGA"
        ],
        "generic_name": [
          "ANSUVIMAB"
        ],
        "manufacturer_name": [
          "Emergent Manufacturing Operations Baltimore, LLC",
          "Ridgeback Biotherapeutics, LP"
        ],
        "product_ndc": [
          "71655-578",
          "80673-777"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "ANSUVIMAB"
        ],
        "rxcui": [
          "2472156",
          "2472161"
        ],
        "spl_id": [
          "96de39df-510a-452f-9609-7356da2231ba",
          "2dcc24f9-c86e-1693-e063-6394a90ac147"
        ],
        "spl_set_id": [
          "de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5",
          "9c008384-379d-48d3-b5a5-9809ed0f655c"
        ],
        "package_ndc": [
          "71655-578-01",
          "71655-578-02",
          "71655-578-03",
          "71655-578-04",
          "71655-578-08",
          "80673-777-01",
          "80673-777-04",
          "80673-777-08",
          "80673-001-01",
          "80673-001-36"
        ],
        "nui": [
          "N0000194038",
          "N0000194037"
        ],
        "pharm_class_epc": [
          "Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]"
        ],
        "pharm_class_moa": [
          "Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA]"
        ],
        "unii": [
          "TG8IQ19NG2"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "EBANGA",
          "active_ingredients": [
            {
              "name": "ANSUVIMAB-ZYKL",
              "strength": "400MG/VIAL"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "POWDER",
          "route": "IV (INFUSION)",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}